Promising results shown with targeted approaches in subsets of non-small cell lung cancer
9/30/2014
The BRAF inhibitor dabrafenib has significant anti-tumour activity in patients with advanced BRAF V600E mutant non-small cell lung cancer whose disease has progressed after chemotherapy, according...
Studies report new findings on treatment options for mesothelioma
9/30/2014
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to...
Patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in...
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage...
A growing number of oncologists in Greece are female, but women continue to be under-represented in leadership positions, according to a survey reported at the ESMO 2014 Congress.
Many patients lack information about the use of targeted therapies, oncologists say
9/30/2014
More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey...
Docs toolkits to tackle treatment of blood poisoning, UK
9/30/2014
A Good Hope Hospital consultant is changing the way treatment of blood poisoning is managed by health care professionals with a suite of new toolkits.
Sun's UV radiation rendered harmless by skin pigment
9/30/2014
Researchers at Lund University in Sweden and other institutions have worked out how the pigment of the skin manages to protect the body from the sun's dangerous UV rays.
Cancer survivors excluded from lung cancer clinical trials
9/30/2014
Lung cancer clinical trials exclude a substantial proportion of patients due to a history of prior cancer, as shown in an analysis by cancer researchers at UT Southwestern Medical Center.
Scan may identify lung cancer patients who will benefit from folate-targeted drug
9/30/2014
Study using thymidylate synthase as a predictive and prospective biomarker; Report on a trial with a drug that targets the folate receptorMeasuring the expression levels of an enzyme involved in...